Unlocking the Potential: New Data from BROOKLYN Clinical Trial of Obicetrapib for Heterozygous Familial Hypercholesterolemia Presented at AHA Conference by NewAmsterdam Pharma

NewAmsterdam Pharma Reports Positive Results from Phase 3 Trial of Obicetrapib Key Findings: Met Primary Endpoint: The Phase 3 BROOKLYN clinical trial of obicetrapib showed a significant reduction in LDL-C levels compared to placebo. The mean reduction was 36.3% at day 84 and 41.5% at day 365. Lp(a) Reduction: Patients in the trial also experienced…

Read More

JinkoSolar Shines Bright: Topping Wood Mackenzie’s Global Solar Module Manufacturers Ranking for 2025

JinkoSolar’s Triumph: No.1 Solar Module Manufacturer in the World Shangrao, China, February 10, 2025 – In an electrifying announcement, JinkoSolar Holding Co., Ltd. (JinkoSolar or the Company), a global solar industry leader, claimed the top spot in the Global Solar Module Manufacturers Ranking 2025 report published by Wood Mackenzie. This prestigious recognition is a testament…

Read More

Centerpoint Energy Successfully Weathers Winter Storm Enzo: Over 99% of Customers Maintain Power Amidst Extreme Conditions, Emergency Operations Center Deactivated

CenterPoint Energy Restores Electric Service to 99% of Customers After Winter Storm CenterPoint Energy, the leading electric and natural gas utility company in the Houston area, announced on January 22, 2025, that it had successfully restored electric service to nearly all of its customers following the historic Winter Storm Enzo. The company’s Emergency Operations Center…

Read More

FiscalNote Holdings, Inc.: The Surprising Upgrade to a ‘Buy’ Rating – A Tale of Zacks Rank and Market Moves

FiscalNote’s Bright Prospects: A Zacks Rank #2 Upgrade Explained Hey there, curious cat! Today, I’ve got some exciting news to share about FiscalNote Holdings, Inc. (NOTE), a company that’s been making waves in the tech world. Drumroll, please… The Zacks Investment Research team has upgraded FiscalNote to a Zacks Rank #2 (Buy)! What Does This…

Read More

Breaking News: Alarum Technologies Investors, Wake Up! Levi Korsinsky Drops a Class-Action Lawsuit Bombshell – Don’t Miss the Deadline!

Curious Human: “Hey AI, have you heard about the recent lawsuit against Alarum Technologies Ltd.? I’m an investor, and I’m a bit concerned.” Artificial Intelligence: “Hello there, Curious Human! Yes, I’ve picked up on that. Let me help you understand the situation a bit better.” Alarum Technologies Ltd., a leading innovator in the field of…

Read More

Breaking Barriers: Myriad Genetics Teams Up with Institut für Hamopathologie Hamburg and Centre Georges-François Leclerc to Bring Genetic Testing to Europe

Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, France Latest expansions represent Myriad’s commitment to growing international lab partner program Myriad Genetics, Inc., a leader in genetic testing and precision medicine, has announced two new partnerships with renowned medical institutions in Hamburg, Germany and Dijon, France. These collaborations will bring MyChoice CDx…

Read More